Found: 29
Select item for more details and to access through your institution.
Immunotherapy in Glioblastoma: Current Approaches and Future Perspectives.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 13, p. 7046, doi. 10.3390/ijms23137046
- By:
- Publication type:
- Article
Neutrophil-to-lymphocyte ratio as a predictor of survival in patients with triple-negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2019, v. 174, n. 2, p. 443, doi. 10.1007/s10549-018-05106-7
- By:
- Publication type:
- Article
Immune Checkpoint Inhibitors and Glioblastoma: A Review on Current State and Future Directions.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 2, p. 97, doi. 10.36401/JIPO-23-34
- By:
- Publication type:
- Article
Proton Craniospinal Irradiation with Immunotherapy in Two Patients with Leptomeningeal Disease from Melanoma.
- Published in:
- Journal of Immunotherapy & Precision Oncology, 2024, v. 7, n. 1, p. 1, doi. 10.36401/JIPO-23-20
- By:
- Publication type:
- Article
randomized feasibility study evaluating temozolomide circadian medicine in patients with glioma.
- Published in:
- Neuro-Oncology Practice, 2022, v. 9, n. 3, p. 193, doi. 10.1093/nop/npac003
- By:
- Publication type:
- Article
Editorial: Radiotherapy strategies for precise treatment on brain metastases.
- Published in:
- Frontiers in Oncology, 2024, p. 01, doi. 10.3389/fonc.2024.1366261
- By:
- Publication type:
- Article
Exploring New and Novel Treatments in Neurofibromatosis.
- Published in:
- Oncology (08909091), 2020, v. 34, n. 3, p. 75
- By:
- Publication type:
- Article
A randomized controlled phase III study of VB-111 combined with bevacizumab vs bevacizumab monotherapy in patients with recurrent glioblastoma (GLOBE).
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 705, doi. 10.1093/neuonc/noz232
- By:
- Publication type:
- Article
Optimizing eligibility criteria and clinical trial conduct to enhance clinical trial participation for primary brain tumor patients.
- Published in:
- Neuro-Oncology, 2020, v. 22, n. 5, p. 601, doi. 10.1093/neuonc/noaa015
- By:
- Publication type:
- Article
Biological and therapeutic implications of multisector sequencing in newly diagnosed glioblastoma.
- Published in:
- Neuro-Oncology, 2018, v. 20, n. 4, p. 472, doi. 10.1093/neuonc/nox232
- By:
- Publication type:
- Article
Diagnostic and Therapeutic Strategies for Patients with Malignant Epidural Spinal Cord Compression.
- Published in:
- 2017
- By:
- Publication type:
- journal article
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
- Published in:
- Journal of Translational Medicine, 2018, v. 16, n. 1, p. N.PAG, doi. 10.1186/s12967-018-1507-6
- By:
- Publication type:
- Article
Correction to: First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
First results on survival from a large Phase 3 clinical trial of an autologous dendritic cell vaccine in newly diagnosed glioblastoma.
- Published in:
- 2018
- By:
- Publication type:
- journal article
The predictive value of absolute lymphocyte counts on tumor progression and pseudoprogression in patients with glioblastoma.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Withdrawal of bevacizumab is associated with rebound growth of vestibular schwannomas in neurofibromatosis type 2-related schwannomatosis patients.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad123
- By:
- Publication type:
- Article
Cerebrospinal fluid 2-hydroxyglutarate as a monitoring biomarker for IDH-mutant gliomas.
- Published in:
- Neuro-Oncology Advances, 2023, v. 5, n. 1, p. 1, doi. 10.1093/noajnl/vdad061
- By:
- Publication type:
- Article
Efficacy of laser interstitial thermal therapy (LITT) for newly diagnosed and recurrent IDH wild-type glioblastoma.
- Published in:
- Neuro-Oncology Advances, 2022, v. 4, n. 1, p. 1, doi. 10.1093/noajnl/vdac040
- By:
- Publication type:
- Article
Development of Aplastic Anemia during Treatment of Anaplastic Astrocytoma with Temozolomide.
- Published in:
- Case Reports in Oncology, 2020, v. 13, n. 3, p. 1244, doi. 10.1159/000509744
- By:
- Publication type:
- Article
Hyperthermic Laser Ablation of Recurrent Glioblastoma Leads to Temporary Disruption of the Peritumoral Blood Brain Barrier.
- Published in:
- PLoS ONE, 2016, v. 11, n. 2, p. 1, doi. 10.1371/journal.pone.0148613
- By:
- Publication type:
- Article
Association between severe treatment-related lymphopenia and progression-free survival in patients with newly diagnosed squamous cell head and neck cancer.
- Published in:
- Head & Neck, 2014, v. 36, n. 12, p. 1747, doi. 10.1002/hed.23535
- By:
- Publication type:
- Article
Impact of overall corticosteroid exposure during chemoradiotherapy on lymphopenia and survival of glioblastoma patients.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 143, n. 1, p. 129, doi. 10.1007/s11060-019-03146-7
- By:
- Publication type:
- Article
A multicenter phase II study of temozolomide plus disulfiram and copper for recurrent temozolomide-resistant glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2019, v. 142, n. 3, p. 537, doi. 10.1007/s11060-019-03125-y
- By:
- Publication type:
- Article
Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 138, n. 1, p. 105, doi. 10.1007/s11060-018-2775-y
- By:
- Publication type:
- Article
Impact of concurrent versus adjuvant chemotherapy on the severity and duration of lymphopenia in glioma patients treated with radiation therapy.
- Published in:
- Journal of Neuro-Oncology, 2018, v. 136, n. 2, p. 403, doi. 10.1007/s11060-017-2668-5
- By:
- Publication type:
- Article
Multicenter, prospective, phase II study of maintenance bevacizumab for children and adults with NF2-related schwannomatosis and progressive vestibular schwannoma.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1498, doi. 10.1093/neuonc/noad066
- By:
- Publication type:
- Article
Clinical, histological, and molecular features of gliomas in adults with neurofibromatosis type 1.
- Published in:
- Neuro-Oncology, 2023, v. 25, n. 8, p. 1474, doi. 10.1093/neuonc/noad033
- By:
- Publication type:
- Article
Review of Novel Surgical, Radiation, and Systemic Therapies and Clinical Trials in Glioblastoma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 19, p. 10570, doi. 10.3390/ijms251910570
- By:
- Publication type:
- Article
A Rare Case of Glioblastoma with Osseous Metastases.
- Published in:
- Canadian Journal of Neurological Sciences, 2024, v. 51, n. 3, p. 425, doi. 10.1017/cjn.2023.256
- By:
- Publication type:
- Article